Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions

Fecal Incontinence

Interventions

DRUG

NRL001

10 mg NRL001 in a 2 g suppository, administered once daily for 7 days

DRUG

Placebo control

Matched placebo - administered as a 2 g suppository, once daily for 7 days

Trial Locations (1)

Queens Medical Centre, Nottingham